Cargando…
Oral Delivery of Biologics via the Intestine
Biologics are currently one of the most promising avenues for therapeutic interventions in conditions such as metabolic disease, ageing and inflammatory disorders, and for chronic ailments, oral delivery of such medicines has for years been recognised as an important goal. Despite decades of intensi...
Autor principal: | New, Roger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824380/ https://www.ncbi.nlm.nih.gov/pubmed/33374222 http://dx.doi.org/10.3390/pharmaceutics13010018 |
Ejemplares similares
-
An update on oral drug delivery via intestinal lymphatic transport
por: Zhang, Zichen, et al.
Publicado: (2021) -
Oral Vaccine Delivery for Intestinal Immunity—Biological Basis, Barriers, Delivery System, and M Cell Targeting
por: Kang, Sung Hun, et al.
Publicado: (2018) -
Challenges and Opportunities in the Oral Delivery of Recombinant Biologics
por: Masloh, Solene, et al.
Publicado: (2023) -
Strategies and Mechanism in Reversing Intestinal Drug Efflux in Oral Drug Delivery
por: Lu, Rong, et al.
Publicado: (2022) -
The challenges of oral drug delivery via nanocarriers
por: Reinholz, Jonas, et al.
Publicado: (2018)